GlassScriptPhysician profile
Danielle Nicole Craig
NPI 1417321779
$4,065.83
in general payments reported to CMS, 2019-2025
38 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $925 · 2022: $694 · 2023: $1,671 · 2024: $667 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,783 · Travel and Lodging: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,783.22 |
| Travel and Lodging | $664.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,383.01 | 2023-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $271.53 | 2023-2025 | Gemtesa |
| Abbvie INC. | $213.93 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $207.07 | 2021-2022 | |
| Daiichi Sankyo INC. | $194.80 | 2021-2023 | Injectafer |
| Novo Nordisk INC | $192.86 | 2021-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $190.12 | 2021-2023 | Breztri |
| Pfizer INC. | $187.54 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $158.65 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $145.42 | 2021-2023 | Verquvo, Belsomra, Steglatro |
| Esperion Therapeutics, INC. | $106.40 | 2021 | |
| Procept Biorobotics Corporation | $99.23 | 2024 | Aquabeam System |
| Dexcom, INC. | $75.20 | 2021-2024 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $62.37 | 2021-2022 | |
| Mylan Specialty L.P. | $58.42 | 2021-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $52.47 | 2024 | Cysview |
| Laborie Medical Technologies Corp. | $51.68 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Amgen INC. | $46.99 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $31.91 | 2021 | |
| Astellas Pharma US INC | $30.31 | 2023 | Veozah |
| Lilly USA, LLC | $28.76 | 2021 | |
| Tolmar, INC. | $22.61 | 2024 | |
| Medtronic, INC. | $21.67 | 2023 | Interstim |
| Sun Pharmaceutical Industries INC. | $21.41 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $21.05 | 2022 | |
| Urogen Pharma, INC. | $20.95 | 2023 | Jelmyto |
| Seqirus USA INC | $19.76 | 2021 | |
| Endo Pharmaceuticals INC. | $17.55 | 2023 | Xiaflex |
| Baxter Healthcare | $14.88 | 2023 | Hillrom - Life 2000 Ventilation System |
| Eisai INC. | $14.19 | 2021 | |
| Exact Sciences Corporation | $14.11 | 2023 | Cologuard Collection Kit |
| Ironwood Pharmaceuticals, INC | $13.70 | 2022 | |
| Xeris Pharmaceuticals, INC. | $13.52 | 2021 | |
| Corcept Therapeutics | $12.84 | 2022 | |
| Amarin Pharma, INC. | $12.62 | 2021 | |
| Sunovion Pharmaceuticals INC. | $12.47 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.07 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Craig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.